1993Leukemia & lymphoma/Leukemia and lymphomaRequires access

Immunophenotype of Acute Lymphoblastic Leukemia Cells: The Experience of the Italian Cooperative Group (Gimema)

Giulio De Rossi, Carlo Enrico Grossi, Robin Foà, Antonio Tabilio, Luce Vegna, Francesco Lo‐Coco, Luciana Annino, Andrea Camera, Nicola Cascavilla, Stefani Ciolli, Giovanni Del Poeta, Vincenzo Liso, Franco Mandelli

Open publisher page 21 citations

Abstract

The immunophenotype of 304 adult lymphoblastic leukemias (> 18 years) diagnosed on the basis of the FAB criteria was determined at the time of diagnosis using a panel of monoclonal antibodies. The series comprised cases diagnosed and immunophenotyped in 43 Italian centers (GIMEMA Cooperative Group) between April 1988 and June 1991. The immunophenotypic characterization consisted of two consecutive steps. The initial screening was based on the reactivity for Tdt, HLA-Dr, CD7, CD10, CD13, CD19, CD24, CD33 and CD41. According to the results obtained, the second level of investigation assessed the positivity for intra cytoplasmic (Cy) Ig, CD la, CD2, CD3, CD4, CDS, CDS and CD20. Based on the hierarchial expression of the different B- and T-cell related antigens, each case was assigned to a given differentiation stage. B-lineage ALL were classified in five subgroups (B0-B4) and T-lineage ALL in four subgroups (T0-T3). Cases in which the blasts were lymphoid according to the FAB criteria, but expressed myeloid antigens in association with B- and T-lymphoid markers were defined as hybrid leukemias.As expected, CD10 + cases (B2-B3) were the most frequent within the B-lineage ALL (83.2% of cases). Cylg+ (B3) accounted for about 20% of CD10+ ALL. Twenty eight cases (13.4%) were at a pre-cALL stage (B0-B1) and of these, 8 (3.8% of the total series) were positive only for TdT and HLA-Dr (BO). Intermediate and mature thymic phenotypes (T2-T3) were predominant within the T-ALL (67.2%) groups. Five cases, were positive only for TdT and CD7 (CD5 +), and classified as T0. 9.2% of cases fulfilled the definition of hybrid leukemia, largely in view of the co-expression of B-lymphoid and myeloid markers. In most cases the cells were at a B2 stage of differentiation. Analysis at the DNA level, carried out in 6 cases, showed that all had a monoclonal rearrangement of the Ig heavy chain gene, sometimes coupled with concomitant TCR gene rearrangement.Mediastinal enlargement was found in 38.9% of the T-ALL cases, but was undetectable in the other subgroups. Anemia was more pronounced in B-lineage ALL while high WBC counts were more frequent in T-ALL., where a greater tumor load was documented. Overall, only 7 cases (2.3%) diagnosed as ALL on the basis of the FAB criteria were re-classified as AML after immunologic characterization. The diagnostic role of phenotypic and genotypic analyses is discussed.

About this research paper

What this paper is about

The immunophenotype of 304 adult lymphoblastic leukemias (> 18 years) diagnosed on the basis of the FAB criteria was determined at the time of diagnosis using a panel of monoclonal antibodies. The series comprised cases diagnosed and immunophenotyped in 43 Italian centers (GIMEMA Cooperative Group) between April 1988 and June 1991. The immunophenotypic characterization consisted of two consecutive steps. The initial screening was based on the reactivity for Tdt, HLA-Dr, CD7, CD10, CD13, CD19, CD24, CD33 and CD41. According to the results obtained, the second level of investigation assessed the positivity for intra cytoplasmic (Cy) Ig, CD la, CD2, CD3, CD4, CDS, CDS and CD20. Based on the hierarchial expression of the different B- and T-cell related antigens, each case was assigned to a given differentiation stage. B-lineage ALL were classified in five subgroups (B0-B4) and T-lineage ALL in four subgroups (T0-T3). Cases in which the blasts were lymphoid according to the FAB criteria, but expressed myeloid antigens in association with B- and T-lymphoid markers were defined as hybrid leukemias.As expected, CD10 + cases (B2-B3) were the most frequent within the B-lineage ALL (83.2% of cases). Cylg+ (B3) accounted for about 20% of CD10+ ALL. Twenty eight cases (13.4%) were at a pre-cALL stage (B0-B1) and of these, 8 (3.8% of the total series) were positive only for TdT and HLA-Dr (BO). Intermediate and mature thymic phenotypes (T2-T3) were predominant within the T-ALL (67.2%) groups. Five cases, were positive only for TdT and CD7 (CD5 +), and classified as T0. 9.2% of cases fulfilled the definition of hybrid leukemia, largely in view of the co-expression of B-lymphoid and myeloid markers. In most cases the cells were at a B2 stage of differentiation. Analysis at the DNA level, carried out in 6 cases, showed that all had a monoclonal rearrangement of the Ig heavy chain gene, sometimes coupled with concomitant TCR gene rearrangement.Mediastinal enlargement was found in 38.9% of the T-ALL cases, but was undetectable in the other subgroups. Anemia was more pronounced in B-lineage ALL while high WBC counts were more frequent in T-ALL., where a greater tumor load was documented. Overall, only 7 cases (2.3%) diagnosed as ALL on the basis of the FAB criteria were re-classified as AML after immunologic characterization. The diagnostic role of phenotypic and genotypic analyses is discussed.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The immunophenotype of 304 adult lymphoblastic leukemias (> 18 years) diagnosed on the basis of the FAB criteria was determined at the time of diagnosis using a panel of monoclonal antibodies. The series comprised cases diagnosed and immunophenotyped in 43 Italian centers (GIMEMA Cooperative Group) between April 1988 and June 1991. The immunophenotypic characterization consisted of two consecutive steps. The initial screening was based on the reactivity for Tdt, HLA-Dr, CD7, CD10, CD13, CD19, CD24, CD33 and CD41. According to the results obtained, the second level of investigation assessed the positivity for intra cytoplasmic (Cy) Ig, CD la, CD2, CD3, CD4, CDS, CDS and CD20. Based on the hierarchial expression of the different B- and T-cell related antigens, each case was assigned to a given differentiation stage. B-lineage ALL were classified in five subgroups (B0-B4) and T-lineage ALL in four subgroups (T0-T3). Cases in which the blasts were lymphoid according to the FAB criteria, but expressed myeloid antigens in association with B- and T-lymphoid markers were defined as hybrid leukemias.As expected, CD10 + cases (B2-B3) were the most frequent within the B-lineage ALL (83.2% of cases). Cylg+ (B3) accounted for about 20% of CD10+ ALL. Twenty eight cases (13.4%) were at a pre-cALL stage (B0-B1) and of these, 8 (3.8% of the total series) were positive only for TdT and HLA-Dr (BO). Intermediate and mature thymic phenotypes (T2-T3) were predominant within the T-ALL (67.2%) groups. Five cases, were positive only for TdT and CD7 (CD5 +), and classified as T0. 9.2% of cases fulfilled the definition of hybrid leukemia, largely in view of the co-expression of B-lymphoid and myeloid markers. In most cases the cells were at a B2 stage of differentiation. Analysis at the DNA level, carried out in 6 cases, showed that all had a monoclonal rearrangement of the Ig heavy chain gene, sometimes coupled with concomitant TCR gene rearrangement.Mediastinal enlargement was found in 38.9% of the T-ALL cases, but was undetectable in the other subgroups. Anemia was more pronounced in B-lineage ALL while high WBC counts were more frequent in T-ALL., where a greater tumor load was documented. Overall, only 7 cases (2.3%) diagnosed as ALL on the basis of the FAB criteria were re-classified as AML after immunologic characterization. The diagnostic role of phenotypic and genotypic analyses is discussed.

Key concepts: Immunophenotyping, Lymphoblastic Leukemia, Medicine, Leukemia, Immunology, Oncology, Flow cytometry

Related papers

Back to paper searchBrowse research topicsOriginal source
Immunophenotype of Acute Lymphoblastic Leukemia Cells: The Experience of the Italian Cooperative Group (Gimema) — Research Paper | ScholarLens